Ayahuasca brews from different traditions vary widely in their psychoactive components. Analysis of 102 samples from indigenous, religious, and neoshamanic communities showed that neoshamanic brews contain higher and more variable concentrations of DMT, likely from using larger or more variable amounts of DMT-containing plants. European samples included two instances of analog ayahuasca containing moclobemide, psilocin, DMT, and yuremamine, with very low levels of Banisteriopsis caapi alkaloids, and some used Peganum harmala and Mimosa tenuiflora. No analogs appeared in Brazilian or Santo Daime samples. The findings highlight the need for awareness and ethical self-regulation among practitioners.
Ayahuasca, a traditional medicine, contains active compounds like harmine and harmaline, which have garnered interest in pharmacology and drug studies. In a sample of 150 participants, 70% reported significant psychological benefits after using ayahuasca, highlighting its potential in mental health treatment. Advanced chromatography techniques revealed the unique chemical profile of ayahuasca, enhancing understanding of its effects compared to other psychedelics. This intersection of chemistry, geography, and context archaeology underscores the importance of traditional practices in modern medicine and cannabinoid research.